121 related articles for article (PubMed ID: 9259823)
1. A clinical trial of red-cell concentrate prepared from blood collected in half-strength citrate anticoagulant.
Murphy WG; Palmer JB; Wilson R; Prowse CV; McClelland DB
Transfus Med; 1991 Mar; 1(1):25-9. PubMed ID: 9259823
[TBL] [Abstract][Full Text] [Related]
2. Whole blood storage in citrate and phosphate solutions containing half-strength trisodium citrate: cellular and biochemical studies.
Mishler JM; Darley JH; Cederholm-Williams S; Wright G
J Pathol; 1978 Mar; 124(3):125-39. PubMed ID: 722376
[TBL] [Abstract][Full Text] [Related]
3. Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion.
McCullough J; Weiblen BJ
Minn Med; 1973 Nov; 56(11):980-2. PubMed ID: 4756991
[No Abstract] [Full Text] [Related]
4. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
Moroff G; Dende D
Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
[TBL] [Abstract][Full Text] [Related]
5. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
Wiltshire M; Cardigan R; Thomas S
Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
[TBL] [Abstract][Full Text] [Related]
6. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO.
Vecchione JJ; Melaragno AJ; Hollander A; Defina S; Emerson CP; Valeri CR
Transfusion; 1982; 22(3):206-9. PubMed ID: 7090033
[TBL] [Abstract][Full Text] [Related]
7. Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies.
Gulliksson H; Eriksson L; Högman CF; Payrat JM
Vox Sang; 1995; 68(3):152-9. PubMed ID: 7625071
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol.
Antonelou MH; Kriebardis AG; Stamoulis KE; Economou-Petersen E; Margaritis LH; Papassideri IS
Transfusion; 2010 Feb; 50(2):376-89. PubMed ID: 19874562
[TBL] [Abstract][Full Text] [Related]
9. Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood services.
McEvoy PM; Kahn RA; Miller WV
Transfusion; 1982; 22(6):532-4. PubMed ID: 7147334
[TBL] [Abstract][Full Text] [Related]
10. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
[TBL] [Abstract][Full Text] [Related]
11. A clinical evaluation of citrate-phosphate-dextrose-adenine blood.
Kreuger A; Akerblom O; Högman CF
Vox Sang; 1975; 29(2):81-9. PubMed ID: 807039
[TBL] [Abstract][Full Text] [Related]
12. Collection and storage of red blood cells with anticoagulant and additive solution with a physiologic pH.
Burger P; Korsten H; Verhoeven AJ; de Korte D; van Bruggen R
Transfusion; 2012 Jun; 52(6):1245-52. PubMed ID: 22233266
[TBL] [Abstract][Full Text] [Related]
13. The in vivo survival of red blood cells stored in modified CPD with adenine: report of a multi-institutional cooperative effort.
Zuck TF; Bensinger TA; Peck CC; Chillar RK; Beutler E; Button LN; McCurdy PR; Josephson AM; Greenwalt TJ
Transfusion; 1977; 17(4):374-82. PubMed ID: 878003
[TBL] [Abstract][Full Text] [Related]
14. Studies on the procurement of blood coagulation factor VIII. In vivo studies on blood components prepared in half-strength citrate anticoagulant.
Griffin B; Bell K; Prowse C
Vox Sang; 1988; 54(4):193-8. PubMed ID: 3133879
[TBL] [Abstract][Full Text] [Related]
15. Citrate-phosphate-dextrose: an improved anticoagulant preservative solution for human blood.
Gibson JG
Vox Sang; 1967 Jul; 13(1):106-7. PubMed ID: 6035803
[No Abstract] [Full Text] [Related]
16. The storage of hard-packed red blood cells in citrate-phosphate-dextrose (CPD) and CPD-adenine (CPDA-1).
Beutler E; West C
Blood; 1979 Jul; 54(1):280-4. PubMed ID: 444671
[TBL] [Abstract][Full Text] [Related]
17. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
Prowse C; Waterston YG; Dawes J; Farrugia A
Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
[TBL] [Abstract][Full Text] [Related]
18. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
Jeter EK; Gadsden RH; Cate J
Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
[TBL] [Abstract][Full Text] [Related]
19. In vitro properties of red cells prepared from half-strength citrate CPD/RAS-2 (Erythro-sol) donations in PL-146 plastic.
Hornsey VS; MacDonald S; Drummond O; Bethel H; Walker B; Prowse CV
Transfus Med; 2000 Mar; 10(1):31-5. PubMed ID: 10760201
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycolysis in platelet storage. IV. The effect of supplemental glucose and adenine.
Beutler E; Kuhl W
Transfusion; 1980; 20(1):97-100. PubMed ID: 7355479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
